Autopsy report · NCT00123799

Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection

“sufficient enrollment reached”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month after it had already started.
• Ran for about 2 years 10 months before it stopped.
• 199 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

AHS Cancer Control Alberta

Sponsor type

University, hospital or other

Conditions

Breast Neoplasms

Interventions

Positron Emission Tomography Imaging

Participants

199

Sites

1

Countries

Canada

Trials that died the same way

• Development of Auditory Skills in Young Deaf Children With Bilateral Cochlear Implants
  “Not sufficient enrollment” (86% match in meaning)
• Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation
  “Insufficient enrollment” (74% match in meaning)
• Treatment Prior to Injection and Biopsy of the Vulva
  “Not enough enrollment” (72% match in meaning)
• Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus
  “enrollment not satisfied” (71% match in meaning)
• Spine and Tumor Screening and Supplementation
  “No enrollment” (71% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.